A Google Research post dated 21 August 2026 describes a tool that prioritises candidate biomarkers from continuous wearable-sensor recordings, narrowing the field of signals worth investigating rather than leaving researchers to sift the whole stream.
What it means for your work
Wearables produce far more signal than anyone can chase, so the useful product is the shortlist rather than the stream.
Our read on the items that move something. The reporting is everyone's; this part is ours.
1
Credit decides patents, publications and funding, so the attribution convention set now will price the next decade of AI-assisted discovery.When a model proposes the molecule, who gets credit for the drug?The Healthcare Operations beat · MIT Technology Review
2
Regulatory clearance is what decides whether an imaging model reaches a real clinic, and Centiloid output is what makes one hospital’s number comparable to another’s.FDA clears automated PET software that puts a number on amyloid burdenThe Healthcare Operations beat · Imaging Technology News
3
The interesting claim is not the robot, it is the flywheel: an operator with a fleet in the field compounds its own deployment data into the next version — the moat any services business should be asking whether it is building.Diligent starts rolling out Moxi 2.0, shaped by five years of hospital fleet dataThe Robotics & Physical AI beat · Diligent Robotics
Following opens with early access — sign up for early access to register your interest; it does not switch following on today. Everything you follow will land on one page, in your account menu.
All coverage
Everything Intel has read, newest first. Each title opens at its original publisher.
Surgical-robot policy work has been gated on scarce hardware time; a faster-than-real-time simulator with published weights moves that loop onto one workstation GPU.